Catalyst Wire Dossier Catalyst Wire Dossier

ABC/3TC

abacavir/lamivudine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABC/3TC, covering 2018-07-23 to 2019-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL) [Phase 3]

See pricing